Polymerase chain reaction detection of circulating melanocytes as a prognostic marker in patients with melanoma.

No abstract is available for this paper.

• Publication year

  1995

• Venue

  Archives of Dermatology

• Publication date

  1995-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1001/ARCHDERM.1995.01690160071011PMID 7726587
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Hematogenous spread of malignant melanoma cells in different stages of disease.

  1993cited by this paper
• Detection of melanoma cells in peripheral blood by means of reverse transcriptase and polymerase chain reaction.

  1991cited by this paper
• The influence of surgical trauma on experimental metastasis

  1989cited by this paper
• Isolation and sequence of a cDNA clone for human tyrosinase that maps at the mouse c-albino locus.

  1987cited by this paper
• Groin dissection in malignant melanoma.

  1986cited by this paper
• Mechanisms of human tumor metastasis studied in patients with peritoneovenous shunts.

  1984cited by this paper
• Prognostic factors in metastatic malignant melanoma. The southeastern cancer study group experience

  1982cited by this paper
• Metastasis: quantitative analysis of distribution and fate of tumor emboli labeled with 125 I-5-iodo-2'-deoxyuridine.

  1970cited by this paper
• Metastasis: Quantitative Analysis of Distribution and Fate of Tumor Emboli Labeled With 125I-5-Iodo-2′ -deoxyuridine

  1970cited by this paper

• Diagnosis of Stage IV Melanoma

  2020cites this paper
• Prognostic Factors in Cutaneous Melanoma

  2014cites this paper
• Detection methods of circulating tumor cells in cutaneous melanoma: a systematic review.

  2014cites this paper
• Expresión de las isoformas del factor de transcripción asociado a microftalmia (mitf) en sangre periférica de pacientes con melanoma maligno cutáneo

  2011cites this paper
• Circulating tumor cells in uveal melanoma.

  2011cites this paper
• Galectin-3 and CD44v6 as Markers for Preoperative Diagnosis of Thyroid Cancer by RT-PCR

  2011cites this paper
• Quantitative detection of melanoma‐associated antigens by multimarker real‐time RT‐PCR for molecular staging: results of a 5 years study

  2010cites this paper
• Tyrosinase expression as a molecular marker for investigating the presence of circulating tumor cells in melanoma patients.

  2010cites this paper
• Prognostic value of microphthalmia-associated transcription factor and tyrosinase as markers for circulating tumor cells detection in patients with melanoma

  2010cites this paper
• Lentigines, nevi, and melanomas

  2010cites this paper
• Old and new serological biomarkers in melanoma: where we are in 2009

  2010cites this paper
• [Molecular detection of minimal residual disease in melanoma and solid tumors].

  2009cites this paper
• Molecular markers detecting circulating melanoma cells by reverse transcription polymerase chain reaction: methodological pitfalls and clinical relevance

  2009cites this paper
• Detección molecular de enfermedad mínima residual en melanoma y otros tumores sólidos

  2009cites this paper
• An ectopic synthesis of the melanin in the adipocytes of the morbidly obese subjects

  2008cites this paper
• Molecular and biochemical testing in stage III melanoma: multimarker reverse transcriptase‐polymerase chain reaction assay of lymph fluid after lymph node dissection and preoperative serum lactate dehydrogenase level

  2008cites this paper
• Thyroid fine‐needle aspiration samples inadequate for reverse transcriptase‐polymerase chain reaction analysis

  2008cites this paper
• Galectin‐3 and CD44v6 positivity by RT‐PCR method in fine needle aspirates of benign thyroid lesions

  2007cites this paper
• Detection of disseminated melanoma cells by reverse-transcription - polymerase chain reaction.

  2007cites this paper
• [Detection of circulating malignant cells in patients with uveal melanoma].

  2007cites this paper
• Clinical significance of the RT‐PCR positive sentinel node in melanoma

  2007cites this paper
• Prognostic role of circulating melanoma cells detected by reverse transcriptase-polymerase chain reaction for tyrosinase mRNA in patients with melanoma

  2007cites this paper
• Molecular markers of circulating melanoma cells.

  2007cites this paper
• Pesquisa de células malignas circulantes em pacientes com melanoma maligno de coróide

  2007cites this paper
• Issues affecting molecular staging in the management of patients with melanoma

  2007cites this paper
• Identification of circulating malignant cells and its correlation with prognostic factors and treatment in uveal melanoma. A prospective longitudinal study

  2007cites this paper
• Toxicogenomics of A375 human malignant melanoma cells.

  2007cites this paper
• Prognostic relevance of baseline and sequential peripheral blood tyrosinase expression in 200 consecutive advanced metastatic melanoma patients

  2007cites this paper
• Prognostic significance of tyrosinase mRNA detected by nested RT-PCR in patients with malignant melanoma.

  2006cites this paper
• Malignant melanoma--markers for progression and prognosis in malignant melanoma.

  2006cites this paper
• Molecular detection of tyrosinase transcripts in peripheral blood from patients with malignant melanoma: correlation of PCR sensitivity threshold with clinical and pathologic disease characteristics

  2006cites this paper
• Prognostic Value of RT-PCR Tyrosinase Detection in Peripheral Blood of Melanoma Patients

  2006cites this paper
• The polymerase chain reaction and its application to clinical plastic surgery.

  2006cites this paper
• Klinische Bedeutung des Nachweises minimaler Residualerkrankung bei Leukämien, Lymphomen und soliden Tumoren

  2006cites this paper
• The Clinical Use of Molecular Markers as Predictors of Disease Outcome and Response to Therapy in Malignant Melanoma

  2006cites this paper
• The Prognostic Value of Circulating Tumor Cells in Patients with Melanoma: A Systematic Review and Meta-analysis

  2006cites this paper
• Molecular diagnosis of cutaneous diseases.

  2005cites this paper
• Molecular diagnostics in melanoma.

  2005cites this paper
• Serum Protein S-100 Predicts Clinical Outcome in Patients with Melanoma Treated with Adjuvant Interferon – Comparison with Tyrosinase RT-PCR

  2005cites this paper
• New Developments in the Staging of Melanoma

  2005cites this paper
• Molecular markers in malignant cutaneous melanoma: Gift horse or one‐trick pony?

  2005cites this paper
• Malignant melanoma and fibrothecoma--an ovarian mixed tumor.

  2005cites this paper
• Lack of Prognostic Importance of Reverse-Transcriptase Polymerase Chain Reaction Detection of Circulating Messenger RNA in Patients with Melanoma

  2005cites this paper
• Microphthalmia-associated transcription factor and tyrosinase as markers of melanoma cells in blood of patients with melanoma.

  2004cites this paper
• Prognostic Factors in Cutaneous Malignant Melanoma

  2004cites this paper
• The history and future of melanoma staging

  2004cites this paper
• Prognostic signs in melanoma: state of the art

  2004cites this paper
• RT-PCR tyrosinase expression in the peripheral blood of melanoma patients

  2004cites this paper
• Quantitative Detection of Circulating Tumor Cells in Cutaneous and Ocular Melanoma and Quality Assessment by Real-Time Reverse Transcriptase-Polymerase Chain Reaction

  2004cites this paper
• Detection of Melanoma Cells in the Lymphatic Drainage after Lymph Node Dissection in Melanoma Patients by Using Two-Marker Reverse Transcriptase-Polymerase Chain Reaction Assay

  2004cites this paper
• Neue Strategien und Konzepte in Diagnostik und Nachsorge des malignen Melanoms

  2003cites this paper
• Limitations of the immunocytochemical detection of isolated tumor cells in frozen samples of bone marrow obtained from melanoma patients

  2003cites this paper
• The role of molecular staging in malignant melanoma.

  2003cites this paper
• Changes in the presence of multiple markers of circulating melanoma cells correlate with clinical outcome in patients with melanoma.

  2003cites this paper
• Detection of tyrosinase and tyrosinase-related protein 1 sequences from peripheral blood of melanoma patients using reverse transcription-polymerase chain reaction.

  2003cites this paper
• Patterns of recurrence in patients with melanoma and histologically negative but RT-PCR-positive sentinel lymph nodes.

  2003cites this paper
• Epidermal growth factor receptor mRNA in peripheral blood of patients with pancreatic, lung, and colon carcinomas detected by RT-PCR.

  2003cites this paper
• Detection of nonmelanoma skin cancer micrometastases in lymph nodes by using reverse transcriptase–polymerase chain reaction for keratin 19 mRNA

  2003cites this paper
• Prognostic value of multiple reverse transcription-PCR tyrosinase testing for circulating neoplastic cells in malignant melanoma.

  2003cites this paper
• Staging systems for cutaneous melanoma

  2003cites this paper
• Prognostic value of circulating melanoma cells detected by reverse transcriptase-polymerase chain reaction.

  2003cites this paper
• Prognostic V alue o f C irculating M elanoma C ells D etected b y Reverse T ranscriptase-Po lymerase C hain R eaction

  2003cites this paper
• Biomarkers in melanoma: staging, prognosis and detection of early metastases

  2003cites this paper
• Sampling and the detection of melanoma cells in blood.

  2002cites this paper
• Detection of occult breast cancer cells by amplification of CK19 mRNA by reverse transcriptase-polymerase chain reaction: role of surgical manipulation.

  2002cites this paper
• Quantitative RT-PCR assessment of melanoma cells in peripheral blood during immunotherapy for metastatic melanoma

  2002cites this paper
• New prognostic factors of cutaneous melanoma: a review of the literature

  2002cites this paper
• RT-PCR for tyrosinase expression as a molecular marker in malignant melanoma.

  2002influential citation
• Reverse transcriptase–polymerase chain reaction detection of circulating tumor cells in patients with melanoma: Correlation with clinical stage, tumor thickness and histological type

  2002cites this paper
• Determination of tyrosinase mRNA in melanoma by reverse transcription-PCR and optical mirror resonance biosensor

  2002cites this paper
• Prognostic significance of the sequential detection of circulating melanoma cells by RT–PCR in high-risk melanoma patients receiving adjuvant interferon

  2002influential citation
• Pathologic staging of melanoma.

  2002cites this paper
• Tyrosinase m RNA i n B lood o f P atients W ith M elanoma Treated W ith A djuvant I nterferon

  2002cites this paper
• Quantitative nested real-time RT-PCR specific for tyrosinase transcripts to quantitate minimal residual disease.

  2002cites this paper
• Clinical Prognostic Factors and Staging

  2002cites this paper
• Tyrosinase mRNA in blood of patients with melanoma treated with adjuvant interferon.

  2002cites this paper
• Clinical significance of PCR-positive mRNA markers in peripheral blood and regional nodes of malignant melanoma patients. Melanoma Cooperative Group.

  2001cites this paper
• NY-ESO-1 and CTp11 expression may correlate with stage of progression in melanoma.

  2001cites this paper
• Minimal Residual Disease in Melanoma

  2001cites this paper
• Reliability of PCR-based detection of occult tumour cells: lessons from real-time RT-PCR

  2001cites this paper
• Molecular characterization of minimal residual cancer cells in patients with solid tumors.

  2001cites this paper
• Reverse transcriptase polymerase chain reaction (RT-PCR) detection of melanoma-related transcripts in the peripheral blood and bone marrow of patients with malignant melanoma. What have we learned?

  2001cites this paper
• Evaluation of the use of tyrosinase‐specific and melanA/MART‐1‐specific reverse transcriptase‐coupled–polymerase chain reaction to detect melanoma cells in peripheral blood samples from 299 patients with malignant melanoma

  2001cites this paper
• Quantification of melanoma-associated molecules in plasma/serum of melanoma patients.

  2001cites this paper
• Detection of circulating melanoma cells in peripheral blood by a two-marker RT-PCR assay

  2001cites this paper
• Prognostic Value of Tyrosinase Reverse-Transcriptase Polymerase Chain Reaction in Metastatic Melanoma

  2001cites this paper
• Minimal residual marrow disease: Detection and significance of isolated tumour cells in bone marrow

  2001cites this paper
• Utility of tests for circulating melanoma cells in identifying patients who develop recurrent melanoma.

  2001cites this paper
• Detection of melanoma cells in sentinel lymph nodes, bone marrow and peripheral blood by a reverse transcription–polymerase chain reaction assay in patients with primary cutaneous melanoma: association with Breslow's tumour thickness

  2001cites this paper
• Nested quantitative real time PCR for detection of occult tumor cells.

  2001cites this paper
• Polymerase chain reaction in the detection of circulating tumour cells in peripheral blood of melanoma patients.

  2001cites this paper
• The clinical utility of multimarker RT-PCR in the detection of occult metastasis in patients with melanoma.

  2001cites this paper
• Detection of micrometastasis through tissue-specific gene expression: its promise and problems.

  2001cites this paper
• Disseminierte Melanomzellen in Blut und Knochenmark Bedeutung und Nachweis durch potenzielle Tumormarker

  2001cites this paper
• Interlaboratory evaluation of a new reverse transcriptase polymerase chain reaction-based enzyme-linked immunosorbent assay for the detection of circulating melanoma cells: a multicenter study of the Dermatologic Cooperative Oncology Group.

  2001cites this paper
• A meta-analysis of reverse transcriptase-polymerase chain reaction for tyrosinase mRNA as a marker for circulating tumor cells in cutaneous melanoma.

  2001cites this paper
• Role of RT-PCR tyrosinase detection in the monitoring of patients with advanced metastatic melanoma

  2000cites this paper
• Molecular detection and characterisation of circulating tumour cells and micrometastases in solid tumours.

  2000cites this paper
• Quantitative analysis of tyrosinase and tyrosinase‐related protein‐2 mRNA from melanoma cells in blood by real‐time polymerase chain reaction

  2000cites this paper
• Molecular detection of low‐level disease in patients with cancer

  2000cites this paper